
x-vir 0.5mg Tablet
Salt Composition: Entecavir (0.5 mg)
Expiry Date: 01/2028
Inclusive of all taxes
30 tablet
About The Product
Hepatitis B
X-Vir 0.5mg Tablet is a prescription-based antiviral medicine. It is used in the treatment of Hepatitis B virus (HBV) infection. This medication prevents the Hepatitis B virus from replicating, thereby reducing liver damage. Do not take this medicine in the wrong way, as it may lead to some severe side effects. Store this medicine at room temperature and protect it from heat and direct light.
Side Effects
- X-Vir 0.5mg Tablet may cause some side effects that vary from one patient to another.
- Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
- Common side effects include: Nausea Rash Headache Vomiting Abdominal pain Fatigue Diarrhea Contact your doctor immediately if you experience any severe or unusual side effects.
How To Use
- The dosage of X-Vir 0.5 mg Tablet is determined by the doctor based on your health condition.
- This medication should be taken orally on an empty stomach, or it can be consumed one hour before a meal or two hours after a meal.
- In the event of an overdose, contact your doctor immediately.
Safety Advice
Missed Doses
- It is advisable not to miss a dose.
- If you miss a scheduled dose of x-vir 0.5mg Tablet tablets, contact your doctor immediately.
FAQs
X-Vir 0.5mg Tablet is an antiviral medication that is used in the treatment of Hepatitis B infection.
This medicine prevents the multiplication of HBV in the body.
Reference
1. Robinson, D.
M., Scott, L. J., & Plosker, G.
L. (2006).
Entecavir: a review of its use in chronic hepatitis B. Drugs, 66(12), 1605-1622.
2. Matthews, S.
J. (2006).
Entecavir for the treatment of chronic hepatitis B virus infection. Clinical therapeutics, 28(2), 184-203.
3. Ha, N.
B., Ha, N. B., Trinh, H.
N., Nguyen, H. A., Nguyen, K.
K., & Nguyen, M. H.
(2013). Response to higher dose of entecavir 1.0 mg daily in patients with partial response to entecavir 0.5 mg daily.
Journal of Clinical Gastroenterology, 47(5), 461-465. 4.
Bougueleret, L., Schwarzstein, M., Tsugita, A., & Zabeau, M. Otaracterization of the genes coding for the Eco RV restriction and modification system of.
5. TABLET, U.
O. A.
Altraz Tablet.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
